Beremagene geperpavec (B-VEC) gene therapy for the treatment of cutaneous wounds in patients with dystrophic epidermolysis bullosa: a critical appraisal

Br J Dermatol. 2023 Nov 4:ljad433. doi: 10.1093/bjd/ljad433. Online ahead of print.NO ABSTRACTPMID:37936299 | DOI:10.1093/bjd/ljad433

Source: The British Journal of Dermatology - November 8, 2023 Category: Dermatology Authors: Brent J Doolan John A McGrath Jemima E Mellerio Source Type: research